We are entering the third decade of synthetic biology. Many synbio products are either commercialized or on the verge of commercialization. However, scaling up the production while achieving price parities will require innovation in the processes and unit operations involved. Listen to Subramani Ramachandrappa, founder of Laurus Bio (formerly Richcore Lifesciences) and Fermbox talk about the challenges and potential solutions in the scale up of synthetic biology solutions.

Bio: https://www.linkedin.com/in/subramani-ramachandrappa-7179b82/

Website: https://fermbox.bio/

TechSprouts: https://www.ankurcapital.com/techsprouts